Open AccessFinal analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma ( JCOG1105 )
Author(s) -
Maruyama Dai,
Iida Shinsuke,
Machida Ryunosuke,
Kusumoto Shigeru,
Fukuhara Noriko,
Yamauchi Nobuhiko,
Miyazaki Kana,
Yoshimitsu Makoto,
Kuroda Junya,
Tsukamoto Norifumi,
Tsujimura Hideki,
Usuki Kensuke,
Yamauchi Takahiro,
Utsumi Takahiko,
Mizuno Ishikazu,
Takamatsu Yasushi,
Nagata Yasuyuki,
Ota Shuichi,
Ohtsuka Eiichi,
Hanamura Ichiro,
Suzuki Yasuhiro,
Yoshida Shinichiro,
Yamasaki Satoshi,
Suehiro Youko,
Kamiyama Yutaro,
Fukuhara Suguru,
Tsukasaki Kunihiro,
Nagai Hirokazu
Publication year - 2022
Publication title -
cancer science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.035
H-Index - 141
eISSN - 1349-7006
pISSN - 1347-9032
DOI - 10.1111/cas.15484
Subject(s) - bortezomib , melphalan , multiple myeloma , prednisolone , medicine , oncology , pharmacology